drugset / Trial / NCT06942689

Determination of the Optimal Volume of Liposomal Bupivacaine in Adductor Canal Block for Knee Joint Surgery

NCT06942689 ↗

NaSingle-groupOpen-labelTreatment

Summary

Building on Bayesian design methodologies from volume optimization studies of ropivacaine in shoulder surgery, this study pioneers the application of a seamless dose-finding strategy in knee ACB. Utilizing advanced statistical models (BOIN/BOP2 design), we aim to systematically evaluate the volume-effect relationship of liposomal bupivacaine, providing precise dosing recommendations to advance personalized and optimized analgesic protocols for knee surgery.

Timeline

Start
2025-06-01
Primary completion
2027-12-31
Completion
2027-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 10 ml Other
Subject Bupivacaine Other / unclassified 15 ml Other
Subject Bupivacaine Other / unclassified 20 ml Other
Subject Bupivacaine Other / unclassified 25 ml Other
Subject Bupivacaine Other / unclassified 30 ml Other
Subject Bupivacaine Other / unclassified 35 ml Other
Subject Bupivacaine Other / unclassified 40 ml Other

Indications

No indication recorded.